Resistance of Mycobacterium tuberculosis to antibiotics in Lao PDR: First multicentric study conducted in 3 hospitals

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Iem, Vibol ^a   Somphavong, Silaphet ^a,b   Buisson, Yves ^b   Steenkeste, Nicolas ^a   Breysse, Franck ^c   Chomarat, Monique ^c   Sylavanh, Phannasinh ^d   Nanthavong, Phouratsamy ^e   Rajoharison, Alain ^f   Berland, Jean Luc ^f   Paboriboune, Phimpha ^a  

^a Ministry of Health   (Laos)

^b Institut de la Francophonie pour la Medecine Tropicale   (Laos)

^c Groupement Hospitalier Sud   (France)

^d National Tuberculosis Control Program Center   (Laos)

^e MAHOSOT HOSPITAL   (Laos)

^f Fondation Mérieux Laboratoire des Pathogènes Émergents   (France)

Author keywords

Multicentric; Multidrug resistant TB; Non Tuberculosis Mycobacteria

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LAOS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPUTUM CULTURE; SPUTUM SMEAR;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LAOS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84879045850     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-275     Document Type: Article

References (32)

1. WHO/IUATLD Anti-tuberculosis drug resistance in the world 2008, Geneva, Fourth global report, WHO/IUATLD.
2. WHO/HTM/TB Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010, Geneva, 2010 global report on surveillance and response, WHO/HTM/TB.
3. Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis-critical steps for prevention and control. N Engl J Med 2010, 363:1050-1058.
4. WHO Global Tuberculosis Control Report 2009, Geneva, WHO.
5. Arnadottir TH, Soukaseum H, Vangvichit P, Bounmala S, Vos E. Prevalence and annual risk of tuberculosis infection in Laos. Int J Tuberc Lung Dis 2001, 5:391-399.
6. Barennes H, Keophithoun T, Nguyen TH, Strobel M, Odermatt P. Survival and health status of DOTS tuberculosis patients in rural Lao PDR. BMC Infect Dis 2010, 10:265.
7. Thammavong C, Paboriboune P, Bouchard B, et al. Bleach treatment of sputum samples aids pulmonary tuberculosis screening among HIV-infected patients in Laos. Int J Tuberc Lung Dis 2011, 15:1353-1358.
8. Nair N, Wares F, Sahub S. Tuberculosis in the WHO South-East Asia Region. Bull World Health Organ 2010, 88:164-165.
9. Kubica GP, Dye WE, Cohn ML, Middlebrook G. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxyde for culture of mycobacteria. Am Rev Respir Dis 1963, 87:775-779.
10. Yamada N, Saorith K, Yamakami K, et al. The national tuberculosis drug resistance survey in Cambodia, 2000-2001. Int J Tuberc Lung Dis 2007, 11:1321-1327.
11. Ti T, Lwin T, Mar TT, et al. National anti-tuberculosis drug resistance survey, 2002, in Myanmar. Int J Tuberc Lung Dis 2006, 10:1111-1116.
12. Riantawan P, Punnotok J, Chaisuksuwan R, Pransujarit V. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996. Int J Tuberc Lung Dis 1998, 2:616-620.
13. Huong NT, Lan NT, Cobelens FG, et al. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. J Infect Dis 2006, 194:1226-1232.
14. Yang Y, Li X, Zhou F, Jin Q, Gao L. Prevalence of drug-resistant tuberculosis in Mainland China: systematic review and meta-analysis. PLoS One 2011, 6:e20343.
15. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008, 32:1165-1174.
16. Tolani MP, D'souza DT, Mistry NF. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis 2012, 12:9.
17. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010, 48:1683-1689.
18. Kiet VS, Lan NT, An DD, et al. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2010, 48:2934-2939.
19. Huang WL, Chi TL, Wu MH, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2011, 49:2502-2508.
20. Gagneux S, Burgos MV, DeRiemer K, Encisco A, Muñoz S, Hopewell PC, et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2006, 2:e61.
21. Hazbón MH, Brimacombe M, Bobadilla Del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006, 50:2640-2649.
22. Abe C, Kobayashi I, Mitarai S, et al. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. J Clin Microbiol 2008, 46:2263-2268.
23. Guo H, Seet Q, Denkin S, Parsons L, Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006, 55:1527-1531.
24. Hu Y, Hoffner S, Jiang W, Wang W, Xu B. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study. BMC Infect Dis 2010, 10:43.
25. Goto M, Oka S, Tachikawa N, et al. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. Mol Cell Probes 1995, 9:433-439.
26. Bergval IL, Schuitema ARJ, Klatser PR, Anthony RM. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. J Antimicrob Chemother 2009, 64:515-523.
27. Cardoso RF, Cooksey RC, Morlock GP, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004, 48:3373-3381.
28. Minh NN, Van Bac N, Son NT, Lien VT, Ha CH, Cuong NH, Mai CT, Le TH. Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. J Clin Microbiol 2012, 50:598-601.
29. Jugheli L, Bzekalava N, De Rijk P, Fissette K, Portaels F, Rigouts L. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 2009, 53:5064-5068.
30. Surcouf C, Heng S, Pierre-Audigier C, et al. Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes. BMC Infect Dis 2011, 11:255.
31. Murase Y, Maeda S, Yamada H, et al. Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 2010, 16:94854.
32. Khue PM, Phuc TQ, Hung NV, Jarlier V, Robert J. Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam. Int J Tuberc Lung Dis 2008, 12:763-768.